CLOs on the Move

City National Rochdale

www.cnr.com

 
City National Rochdale works with financial advisors to provide investment management services to high-net-worth clients. Click to learn what we offer.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.cnr.com
  • 400, Park Ave
    New York, NY USA 10022
  • Phone: 213.673.9120

Executives

Name Title Contact Details
Don Delano
Chief Compliance Officer Profile

Similar Companies

Alan Blackmon Investments

Alan Blackmon Investments is a Huntsville, AL-based company in the Financial Services sector.

Adjuvant Capital

Adjuvant was established to scale the impact investment model developed at the Global Health Investment Fund (GHIF).

Yamaha Motor Ventures and Laboratory Silicon Valley

Entrepreneurs often need strong partners in order to scale their businesses. This is particularly true for those developing novel hardware systems, exploring new business models, or growing international ventures. Yamaha Motor Ventures & Laboratory Silicon Valley (YMVSV) exists to accelerate the efforts of teams driving disruptive change. We have the resources and backing of Yamaha Motor Company (Japan), yet the openness and agility of a startup. Promising efforts sometimes raise venture capital. Financing these companies through strategic investment is a portion of our activity. For other ventures, strategic corporate partnerships might mean access to vehicles, technology, teams, hardware, infrastructure, or something else entirely. Whether investment, partnership, or both, we work collaboratively to create the future of industries ranging from personal transportation to industrial automation.

Morgan Joseph

Morgan Joseph's Equity Sales and Trading team provides institutional clients access to the firm's differentiated research product and extensive execution capabilities.

Flagship Pioneering

Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability. Since its launch in 2000, the firm has applied a unique, hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $30 billion in aggregate value. To date, Flagship is backed by >$3 billion of aggregate capital commitments, of which over $1.5 billion has been deployed toward the founding and growth of its pioneering companies alongside >$10 billion of follow-on investments from other institutions.